Position in WVE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,457,657
-$252,348 QoQ
Shares Held
423,005
+13.2% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 237 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 69%
None 31%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. WVE ranks #107 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in WVE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,457,657 | 423,005 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,710,005 | 373,794 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,208,995 | 365,235 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,144,809 | 429,619 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,936,265 | 297,887 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,421,324 | 299,669 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,850,815 | 311,303 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,587,116 | 315,502 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,137,270 | 428,311 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,462,439 | 399,099 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,384,168 | 274,093 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,523,088 | 264,885 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $924,759 | 254,055 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,060,840 | 244,998 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,687,987 | 241,141 | Shares | Defined | 2023-02-13 | |
| 2021-03-31 | $554,075 | 98,766 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $776,131 | 98,619 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,443,961 | 876,792 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,033,172 | 1,059,863 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $28,403,222 | 3,031,294 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||